Medicare Enrolled

Dr. Maha Toma, M.D.

Internal Medicine · Lafayette, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3466 MT DIABLO BLVD, Lafayette, CA 94549
9252844442
In practice since 2007 (19 years)
NPI: 1427108125 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Toma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Toma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Toma

Dr. Maha Toma is an internal medicine specialist in Lafayette, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Toma performed 1,350 Medicare services across 1,122 unique beneficiaries.

Between the years covered by Open Payments, Dr. Toma received a total of $14,358 from 50 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Toma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in CA $14,358 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,350
Medicare services
Top 24% in CA for internal medicine
1,122
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
359 $67 $305
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
268 $55 $210
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
210 $79 $312
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
142 $281 $381
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
142 $36 $70
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
66 $36 $70
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
64 $76 $127
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
46 $11 $106
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $45 $133
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
19 $50 $200
Initial preventive physical examination, new Medicare beneficiary
A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care.
14 $183 $434
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,358
Total received (2018-2024)
Avg $2,051/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,358 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,126
2023
$1,523
2022
$2,662
2021
$2,069
2020
$1,011
2019
$1,956
2018
$3,011

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$477
Boehringer Ingelheim Pharmaceuticals, Inc.
$340
Amgen Inc.
$333
Bayer Healthcare Pharmaceuticals Inc.
$327
Lilly USA, LLC
$250
Exact Sciences Corporation
$151
Sumitomo Pharma America, Inc.
$140
Ipsen Biopharmaceuticals, Inc
$34
Kyowa Kirin, Inc.
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
AstraZeneca Pharmaceuticals LP
$14
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,153
Novo Nordisk Inc
$1,132
PFIZER INC.
$1,055
GlaxoSmithKline, LLC.
$906
AstraZeneca Pharmaceuticals LP
$731
Amgen Inc.
$576
Janssen Pharmaceuticals, Inc
$562
Lilly USA, LLC
$553
E.R. Squibb & Sons, L.L.C.
$483
Teva Pharmaceuticals USA, Inc.
$471
GENZYME CORPORATION
$373
Novartis Pharmaceuticals Corporation
$346
Amarin Pharma Inc.
$331
Bayer Healthcare Pharmaceuticals Inc.
$327
Intuitive Surgical, Inc.
$320
SANOFI-AVENTIS U.S. LLC
$315
Gilead Sciences, Inc.
$250
IBSA Pharma Inc.
$241
AbbVie Inc.
$226
Abbott Laboratories
$223
Exact Sciences Corporation
$186
Becton, Dickinson and Company
$171
ABBVIE INC.
$151
Biohaven Pharmaceutical Holding Company Ltd.
$147
Sumitomo Pharma America, Inc.
$140
Silk Road Medical, Inc.
$129
Biohaven Pharmaceuticals, Inc.
$125
Kowa Pharmaceuticals America, Inc.
$125
Dexcom, Inc.
$123
Vertos Medical, Inc.
$122
Radius Health, Inc.
$120
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Genentech, Inc.
$118
BOSTON SCIENTIFIC CORPORATION
$116
Astellas Pharma US Inc
$112
Merck Sharp & Dohme Corporation
$110
Sanofi Pasteur Inc.
$102
Ethicon US, LLC
$80
AbbVie, Inc.
$71
Avanos Medical
$69
Scilex Pharmaceuticals Inc.
$61
Davol Inc.
$61
Focal Therapeutics, Inc.
$44
Daiichi Sankyo Inc.
$36
Ipsen Biopharmaceuticals, Inc
$34
Dynavax Technologies Corporation
$28
Kyowa Kirin, Inc.
$27
Corium, LLC
$22
Xeris Pharmaceuticals, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
AJOVY · AREXVY · AUSTEDO · AZSTARYS · Aimovig · BASAGLAR · BENLYSTA · BEXSERO · BREO · Biozorb · CHANTIX · CINQAIR · COLOGUARD · CREON · CardioMEMS HF System · Cologuard Collection Kit · Crysvita · DERMABOND PRINEO · DEXCOM G7 GSS (161) · DUPIXENT · Da Vinci Surgical System · ELIQUIS · EMGALITY · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GEMTESA · GVOKE PFS · Heplisav-B · INJECTAFER · JARDIANCE · Kerendia · LINZESS · LOKELMA · LYRICA · Livalo · MITRACLIP · MOUNJARO · MYRBETRIQ · NURTEC ODT · OFEV · ON-Q* PUMP AND ACCESSORIES · Otezla · Ozempic · Phasix Mesh · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SKYRIZI · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · Saxenda · TOUJEO · TRADJENTA · Tirosint · Tresiba · Tymlos · UBRELVY · VISTASEAL · Vascepa · Veozah · Victoza · WATCHMAN · XARELTO · XIFAXAN · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.

Looking for an internal medicine specialist in Lafayette?
Compare internal medicine physicians in the Lafayette area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,788
Per 100K population
240.0
County median income
$125,727
Nearest hospital
KAISER FOUNDATION HOSPITAL - WALNUT CREEK
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Toma is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Toma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Toma performed 359 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Toma receive payments from pharmaceutical companies?
Yes. Dr. Toma received a total of $14,358 from 50 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Toma's costs compare to other internal medicine physicians in Lafayette?
Dr. Toma's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Toma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →